CA-AMERICAN-EXPRESS
31.12.2022 14:01:42 CET | Business Wire | Press release
Today American Express (NYSE:AXP) reopened the newly expanded Centurion Lounge at the San Francisco International Airport (SFO). At 16,000 square feet the lounge is now nearly double in size and features more seating, an additional bar with specialty wine flights curated by sommelier and Centurion Lounge Wine Director Anthony Giglio, and a new menu from San Francisco’s Liholiho Yacht Club Executive Chef Ravi Kapur.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221231005003/en/
American Express Opens 16,000 Square Foot Centurion Lounge at San Francisco International Airport (Photo: Business Wire)
“We’re excited to head into the new year with the opening of our Centurion Lounge at San Francisco International Airport,” stated Pablo Rivero, Vice President & General Manager, Global Lounge Experiences. “With exceptional food, wine and art inspired by Northern California, this well-appointed lounge is designed to leave Card Members feeling refreshed and ready for their travels.”
The Centurion Lounge at SFO will now have more space for eligible Card Members to enjoy, including two wine bars and café areas, additional restrooms, private phone rooms, several private workspaces, and more. The lounge is located in Terminal 3 on the mezzanine level.
LOCALLY SOURCED WINE1
The lounge will feature a new bar where guests can enjoy specialty wine flights highlighting four regional wines curated by renowned wine authority Anthony Giglio. The new bar complements the existing wine wall where guests can sample wines from across California. The wine flights will rotate seasonally, starting today with a Sonoma Chardonnay flight and a Napa Valley Cabernet Sauvignon flight:
Sonoma Chardonnay Flight
- Gundlach Bundschu Sonoma Coast Chardonnay 2020
- Head High Sonoma County Chardonnay 2021
- Sonoma Cutrer Les Pierres Sonoma Valley Chardonnay 2019
- Walt Sonoma Coast Chardonnay 2019
Napa Cabernet Sauvignon Flight
- Emblem Napa Valley Cabernet Sauvignon 2019
- Miner Emily's Cuvee Napa Valley Cabernet Sauvignon 2018
- The Critic Napa Valley Cabernet Sauvignon 2019
- Twenty Rows Napa Valley Reserve Cabernet Sauvignon 2020
“As San Francisco is globally known for its world-class wine, the wine menu in the Centurion Lounge at San Francisco International Airport is fully dedicated to highlighting local California grapes,” said Anthony Giglio, sommelier and Centurion Lounge Wine Director. “For our first-ever wine flight experience, I’m thrilled to feature two of America’s most famous and established wine regions - Sonoma and Napa Valley.”
ELEVATED DINING AND DESIGN
The lounge will offer a new seasonal menu that celebrates Bay Area purveyors from Liholiho Yacht Club Executive Chef Ravi Kapur. The Hawaiian-born, James Beard Award-nominated chef will continue to bring his unique flair to the Centurion Lounge at SFO with dishes inspired by his lineage and family memories including, Kochujang marinated chicken thighs, wild rice and coconut soup, and black vinegar and honey glazed baby carrots.
Consumers appreciate premium dining options when traveling through airport lounges. A recent Amex Trendex* survey found that a majority of respondents (64%) said that premium food and beverage offerings are their favorite parts of airport lounges.
The lounge will showcase two custom floor-to-ceiling wallcoverings by abstract artist Tracie Cheng, and new interior design that takes cues from the local vineyards, landscape, and the iconic San Francisco fog to give guests a sense of relaxation.
UNPARALLELED ACCESS
With more lounge options than any other credit card issuer on the market and the only credit card issuer with a proprietary lounge at SFO, the American Express Global Lounge Collection™ is just one of the many ways American Express supports Card Members through their travels. American Express continues to enhance the Centurion Lounge network through new locations and expanding existing lounges. American Express has announced plans to open new lounge locations at the Reagan National Airport (DCA) in Washington, D.C. and Hartsfield-Jackson Atlanta Airport (ATL) in 2023 and 2024 respectively.
*AMEX TRENDEX METHODOLOGY
This Amex Trendex online poll was conducted between November 4th – November 7th, 2022, among a sample of 2000 Adults with an HHI> 70k+ who travel by plane at least once a year. The interviews were conducted online. Results from the full survey have a margin of error of plus or minus 2 percentage points
ABOUT AMERICAN EXPRESS
American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, linkedin.com/company/american-express, twitter.com/americanexpress, and youtube.com/americanexpress.
Key links to products, services and corporate sustainability information: personal cards, business cards and services, travel services, gift cards, prepaid cards, merchant services, Accertify, Kabbage, Resy, corporate card, business travel, diversity and inclusion, corporate sustainability and Environmental, Social, and Governance reports.
ABOUT THE CENTURION LOUNGE
The Centurion Lounge is the signature lounge program within the broader American Express Global Lounge Collection, which includes access to American Express Centurion Lounges, international American Express lounges, Delta Sky Club® for Card Members flying on Delta, Priority Pass™ Select Lounges upon enrollment, Airspace Lounges, MAG U.S. Escape Lounges and Plaza Premium Lounges--a total of more than 1,400 lounges across 140 countries and counting.
Eligible Card Members can find a lounge at the Global Lounge Collection website or by using the American Express® App. They can also check into select Centurion Lounges through the mobile check-in tool within the American Express® App.
ABOUT SAN FRANCISCO INTERNATIONAL AIRPORT
SFO is excited to welcome travelers back to the skies with an airport experience featuring seamless access, thoughtful amenities, sustainable design and inspiring artwork and exhibits.
For up-to-the-minute departure and arrival information, airport maps and details on shopping, dining, cultural exhibitions, ground transportation and more, visit www.flysfo.com. Follow us on twitter.com/flysfo and facebook.com/flysfo.
Source: American Express Company
Location: U.S.
1 Must be of legal age to consume alcoholic beverages. Please drink responsibly.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221231005003/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom